[1]
|
Gao, S., Li, N., Wang, S., et al. (2020) Lung Cancer in People’s Republic of China. Journal of Thoracic Oncology, 15, 1567-1576. https://doi.org/10.1016/j.jtho.2020.04.028
|
[2]
|
Mantovani, A. (2009) Cancer: Inflaming Metastasis. Nature, 457, 36-37. https://doi.org/10.1038/457036b
|
[3]
|
Mao, Z., Zhang, J., Shi, Y., et al. (2020) CXCL5 Pro-motes Gastric Cancer Metastasis by Inducing Epithelial-Mesenchymal Transition and Activating Neutrophils. Oncogene-sis, 9, Article No. 63. https://doi.org/10.1038/s41389-020-00249-z
|
[4]
|
Chae, Y.K., Galvez, C., Anker, J.F., et al. (2018) Cancer Immunotherapy in a Neglected Population: The Current Use and Future of T-Cell-Mediated Checkpoint Inhibitors in Organ Transplant Patients. Cancer Treatment Reviews, 63, 116-121.
https://doi.org/10.1016/j.ctrv.2017.12.004
|
[5]
|
Durgeau, A., Virk, Y., Corgnac, S., et al. (2018) Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy. Frontiers in Immunology, 9, Article No. 14. https://doi.org/10.3389/fimmu.2018.00014
|
[6]
|
Cho, M.S., Lee, H., Gonzalez-Delgado, R., et al. (2022) Plate-lets Increase the Expression of PD-L1 in Ovarian Cancer. Cancers, 14, Article No. 2498. https://doi.org/10.3390/cancers14102498
|
[7]
|
Templeton, A.J., Mcnamara, M.G., Šeruga, B., et al. (2014) Prog-nostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. JNCI: Jour-nal of the National Cancer Institute, 106, dju124.
https://doi.org/10.1093/jnci/dju124
|
[8]
|
Templeton, A.J., Ace, O., Mcnamara, M.G., et al. (2014) Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. Cancer Epidemiology, Bi-omarkers & Prevention, 23, 1204-1212.
https://doi.org/10.1158/1055-9965.EPI-14-0146
|
[9]
|
Wang, H., Ding, Y., Li, N., et al. (2020) Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Plate-let-Lymphocyte Ratio in Stage IV Advanced Gastric Cancer. Frontiers in Oncology, 10, Article No. 841. https://doi.org/10.3389/fonc.2020.00841
|
[10]
|
Lin, Z., Ma, C., Cao, W., et al. (2022) Prognostic Significance of NLR, PLR, LMR and Tumor Infiltrating T Lymphocytes in Patients Undergoing Surgical Resection for Hilar Cholangi-ocarcinoma. Frontiers in Oncology, 12, Article ID: 908907. https://doi.org/10.3389/fonc.2022.908907
|
[11]
|
Chen, L., Kong, X., Wang, Z., et al. (2020) Pre-Treatment Systemic Immune-Inflammation Index Is a Useful Prognostic Indi-cator in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy. Journal of Cellular and Molecular Medi-cine, 24, 2993-3021. https://doi.org/10.1111/jcmm.14934
|
[12]
|
Xu, F., Xu, P., Cui, W., et al. (2018) Neutro-phil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios May Aid in Identifying Patients with Non-Small Cell Lung Can-cer and Predicting Tumor-Node-Metastasis Stages. Oncology Letters, 16, 483-490. https://doi.org/10.3892/ol.2018.8644
|
[13]
|
张国强. 外周血血小板/淋巴细胞比值在非小细胞肺癌中的诊断价值[J]. 临床合理用药杂志, 2019, 12(30): 173-175.
|
[14]
|
Rimini, M., Casadei-Gardini, A., Ravaioli, A., et al. (2020) Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study. Journal of Clinical Medicine, 9, Article No. 1177. https://doi.org/10.3390/jcm9041177
|
[15]
|
王虹, 王晓磊. 鳞状细胞癌抗原联合中性粒细胞与淋巴细胞比值在肺鳞癌早期诊断中的应用[J]. 内蒙古医科大学学报, 2017, 39(3): 254-256.
|
[16]
|
张诤, 张海娇, 申振涛, 等. NLR与PLR及肿瘤标志物在肺癌和社区获得性肺炎鉴别诊断中的应用价值[J]. 中华医院感染学杂志, 2022, 32(4): 540-544.
|
[17]
|
Zhu, X., Song, H., Chen, Y., et al. (2020) Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Blood to Distinguish Lung Cancer Patients from Healthy Subjects. Disease Markers, 2020, Article ID: 8844698.
https://doi.org/10.1155/2020/8844698
|
[18]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[19]
|
Fan, H., Shao, Z., Xiao, Y., et al. (2015) Incidence and Survival of Non-Small Cell Lung Cancer in Shanghai: A Population-Based Cohort Study. BMJ Open, 5, e9419. https://doi.org/10.1136/bmjopen-2015-009419
|
[20]
|
Cao, W., Yu, H., Zhu, S., et al. (2023) Clinical Significance of Preoperative Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in the Prognosis of Resected Early-Stage Pa-tients with Non-Small Cell Lung Cancer: A Meta-Analysis. Cancer Medicine, 12, 7065-7076. https://doi.org/10.1002/cam4.5505
|
[21]
|
Chen, Y., Wang, W., Zhang, X., et al. (2018) Prognostic Significance of Combined Preoperative Platelet-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio in Patients Undergoing Sur-gery with Stage IB Non-Small-Cell Lung Cancer. Cancer Management and Research, 10, 5411-5422. https://doi.org/10.2147/CMAR.S177320
|
[22]
|
刘建清, 骆华春, 沈志勇, 等. PLR和NLR与Ⅲ期非小细胞肺癌临床特征及同步放化疗联合免疫治疗疗效及预后的相关性[J]. 实用癌症杂志, 2022, 37(5): 763-768.
|
[23]
|
Kartolo, A., Holstead, R., Khalid, S., et al. (2020) Serum Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Prognosticating Immunotherapy Efficacy. Immunotherapy, 12, 785-798.
https://doi.org/10.2217/imt-2020-0105
|
[24]
|
石子宜, 郝吉庆. 外周血炎性标志物与PD-1/PD-L1抑制剂治疗肺癌疗效及预后的相关性[J]. 临床肺科杂志, 2022, 27(10): 1527-1532.
|
[25]
|
Park, E.Y., Kim, Y., Choi, K.H., et al. (2019) Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy. Radiation Oncology Journal, 37, 166-175. https://doi.org/10.3857/roj.2019.00220
|
[26]
|
Guo, M., Li, W., Li, B., et al. (2019) Prognostic Value of Delta In-flammatory Biomarker-Based Nomograms in Patients with inoperable Locally Advanced NSCLC. International Im-munopharmacology, 72, 395-401.
https://doi.org/10.1016/j.intimp.2019.04.032
|
[27]
|
He, Q., Li, Y., Zhou, X., et al. (2021) The Combination of Fi-brinogen Concentrations and the Platelet-to-Lymphocyte Ratio Predicts Survival in Patients with Advanced Lung Ade-nocarcinoma Treated with EGFR-TKIs. Journal of International Medical Research, 49, No. 4. https://doi.org/10.1177/03000605211004021
|
[28]
|
Deng, C., Zhang, N., Wang, Y., et al. (2019) High Systemic Immune-Inflammation Index Predicts Poor Prognosis in Advanced Lung Adenocarcinoma Patients Treated with EGFR-TKIs. Medicine, 98, e16875.
https://doi.org/10.1097/MD.0000000000016875
|
[29]
|
Paliogiannis, P., Fois, A.G., Sotgia, S., et al. (2018) Neu-trophil to Lymphocyte Ratio and Clinical Outcomes in COPD: Recent Evidence and Future Perspectives. European Res-piratory Review, 27, Article ID: 170113.
https://doi.org/10.1183/16000617.0113-2017
|
[30]
|
Dai, G., Jiang, Z., Sun, B., et al. (2020) Caffeic Acid Phenethyl Ester Prevents Colitis-Associated Cancer by Inhibiting NLRP3 Inflammasome. Frontiers in Oncology, 10, Article No. 721. https://doi.org/10.3389/fonc.2020.00721
|
[31]
|
Gao, L., Li, J., Yang, R., et al. (2022) Biological Characteriza-tion and Clinical Value of OAS Gene Family in Pancreatic Cancer. Frontiers in Oncology, 12, Article ID: 884334. https://doi.org/10.3389/fonc.2022.884334
|
[32]
|
Delprat, V., Huart, C., Feron, O., et al. (2022) The Impact of Mac-rophages on Endothelial Cells Is Potentiated by Cycling Hypoxia: Enhanced Tumor Inflammation and Metastasis. Fron-tiers in Oncology, 12, Article ID: 961753.
https://doi.org/10.3389/fonc.2022.961753
|
[33]
|
Luo, H., Xu, H., Du, Z., et al. (2020) Prognostic Significance of Baseline Neutrophil Count and Lactate Dehydrogenase Level in Patients with Esophageal Squamous Cell Cancer Treated with Radiotherapy. Frontiers in Oncology, 10, Article No. 430. https://doi.org/10.3389/fonc.2020.00430
|
[34]
|
Nøst, T.H., Alcala, K., Urbarova, I., et al. (2021) Systemic Inflammation Markers and Cancer Incidence in the UK Biobank. European Journal of Epidemiology, 36, 841-848. https://doi.org/10.1007/s10654-021-00752-6
|
[35]
|
Biswas, T., Gawdi, R., Jindal, C., et al. (2021) Pretreatment Neutrophil-to-Lymphocyte Ratio as an Important Prognostic Marker in Stage III Locally Advanced Non-Small Cell Lung Cancer: Confirmatory Results from the PROCLAIM Phase III Clinical Trial. Journal of Thoracic Disease, 13, 5617-5626. https://doi.org/10.21037/jtd-21-1018
|
[36]
|
侯鹏飞, 李忠诚. 外周血中性粒细胞与淋巴细胞比率与非小细胞肺癌相关性的研究进展[J]. 中国现代医药杂志, 2019, 21(12): 100-104.
|